Aim: To explore the hepatoprotective effects and mechanism of miRNA-544 in septic mice, C57BL/6J mice were intraperitoneally injected with lipopolysaccharide (LPS, 5 mg/kg) and treated with miR-544 inhibitors and mimics.
Methods: The aspartate aminotransferase (AST), alanine aminotransferase (ALT) activities and total bilirubin (TBIL) levels were measured by automatic biochemical analyzer. The expression of proteins (MCP-1, CD16/32 and NF-κB inflammatory signaling pathways) and genes (inflammatory factors TNF-α, IL-6 and IL-1β)were measured by immunohistochemistry, western blot, qRT-PCR and ELISA.
Results:The results indicated that miR-544 significantly reduced the level of ALT, AST and TBIL in serum and liver. Meanwhile, miR-544 attenuated the aggravation of inflammation by inhibiting MCP-1 and CD16/32, and suppressed IKK/NF-κB signal pathway by inhibiting the phosphorylation of IKK, IκB and NF-κB, thereby affecting the expression of inflammatory factors.
Conclusions: miR-544 can attenuate LPS-induced liver injury in mice with sepsis via inhibiting the IKK/NF-κB signal pathway, and it is a potential candidate marker and therapeutic target for sepsis-induced liver injury.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.